Aprogen Biologics Inc. (KRX:003060)
1,445.00
-21.00 (-1.43%)
At close: Oct 13, 2026
| Market Cap | 23.39B -80.4% |
| Revenue (ttm) | 86.18B +26.1% |
| Net Income | -78.30B |
| EPS | -5,853.18 |
| Shares Out | 16.18M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 84,293 |
| Open | 1,464.00 |
| Previous Close | 1,466.00 |
| Day's Range | 1,424.00 - 1,485.00 |
| 52-Week Range | 1,445.00 - 9,945.00 |
| Beta | -0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |